PSUF
VRTX icon

People's United Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

People's United Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$216K Sell
829
-136
-14% -$32.3K 0.01% 594
2021
Q4 		$212K Buy
+965
New +$188K 0.01% 645
2021
Q1 		– Sell
-1,089
Closed -$257K – 711
2020
Q4 		$257K Sell
1,089
-455
-29% -$104K 0.01% 586
2020
Q3 		$420K Sell
1,544
-38
-2% -$10.5K 0.01% 466
2020
Q2 		$459K Buy
1,582
+128
+9% +$34.7K 0.01% 439
2020
Q1 		$346K Sell
1,454
-3,064
-68% -$703K 0.01% 446
2019
Q4 		$989K Buy
4,518
+32
+0.7% +$6.48K 0.03% 356
2019
Q3 		$760K Sell
4,486
-132
-3% -$23.4K 0.02% 428
2019
Q2 		$847K Sell
4,618
-2,982
-39% -$521K 0.02% 428
2019
Q1 		$1.4M Buy
7,600
+106
+1% +$19.6K 0.04% 314
2018
Q4 		$1.24M Sell
7,494
-44
-0.6% -$7.62K 0.04% 316
2018
Q3 		$1.45M Buy
7,538
+44
+0.6% +$7.83K 0.04% 283
2018
Q2 		$1.27M Sell
7,494
-164
-2% -$25.4K 0.03% 383
2018
Q1 		$1.25M Sell
7,658
-1
-0% -$163 0.04% 323
2017
Q4 		$1.15M Buy
+7,659
New +$1.13M 0.04% 348

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

People's United Financial's VRTX Position: Q1 2022 in Review

People's United Financial reduced its Vertex Pharmaceuticals (VRTX) stake by 14% in Q1 2022, selling an estimated $32.3K and leaving 829 shares worth $216K. The position accounts for 0.01% of the portfolio, ranked #594.

People's United Financial first reported a position in VRTX in Q4 2017 and has held it in 15 quarters since. The position peaked at $1.45M in Q3 2018. 1,072 funds tracked by Wall St. Rank hold VRTX as of Q1 2022.

  • People's United Financial held 829 shares of Vertex Pharmaceuticals worth $216K as of Q1 2022.
  • People's United Financial sold 136 Vertex Pharmaceuticals shares in Q1 2022, an estimated $32.3K.
  • Vertex Pharmaceuticals made up 0.01% of People's United Financial's portfolio in Q1 2022, its #594 holding.
  • People's United Financial first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 15 quarters since.
  • People's United Financial's Vertex Pharmaceuticals position peaked at $1.45M in Q3 2018.
  • 1,072 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.